Literature DB >> 26669487

A Tumor Suppressor Function for Notch Signaling in Forebrain Tumor Subtypes.

Claudio Giachino1, Jean-Louis Boulay2, Robert Ivanek3, Alvaro Alvarado4, Cristobal Tostado2, Sebastian Lugert3, Jan Tchorz5, Mustafa Coban3, Luigi Mariani2, Bernhard Bettler5, Justin Lathia4, Stephan Frank6, Stefan Pfister7, Marcel Kool7, Verdon Taylor8.   

Abstract

In the brain, Notch signaling maintains normal neural stem cells, but also brain cancer stem cells, indicating an oncogenic role. Here, we identify an unexpected tumor suppressor function for Notch in forebrain tumor subtypes. Genetic inactivation of RBP-Jκ, a key Notch mediator, or Notch1 and Notch2 receptors accelerates PDGF-driven glioma growth in mice. Conversely, genetic activation of the Notch pathway reduces glioma growth and increases survival. In humans, high Notch activity strongly correlates with distinct glioma subtypes, increased patient survival, and lower tumor grade. Additionally, simultaneous inactivation of RBP-Jκ and p53 induces primitive neuroectodermal-like tumors in mice. Hence, Notch signaling cooperates with p53 to restrict cell proliferation and tumor growth in mouse models of human brain tumors.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Hes5; Notch signaling; brain tumor; glioma; primitive neuroectodermal tumor

Mesh:

Substances:

Year:  2015        PMID: 26669487     DOI: 10.1016/j.ccell.2015.10.008

Source DB:  PubMed          Journal:  Cancer Cell        ISSN: 1535-6108            Impact factor:   31.743


  38 in total

Review 1.  Notch as a tumour suppressor.

Authors:  Craig S Nowell; Freddy Radtke
Journal:  Nat Rev Cancer       Date:  2017-02-03       Impact factor: 60.716

2.  Diminished microRNA-29b level is associated with BRD4-mediated activation of oncogenes in cutaneous T-cell lymphoma.

Authors:  Rebecca Kohnken; Jing Wen; Bethany Mundy-Bosse; Kathleen McConnell; Ashleigh Keiter; Leah Grinshpun; Alex Hartlage; Max Yano; Betina McNeil; Nitin Chakravarti; Basem William; James E Bradner; Michael A Caligiuri; Pierluigi Porcu; Anjali Mishra
Journal:  Blood       Date:  2017-11-27       Impact factor: 22.113

3.  Adaptive Chromatin Remodeling Drives Glioblastoma Stem Cell Plasticity and Drug Tolerance.

Authors:  Brian B Liau; Cem Sievers; Laura K Donohue; Shawn M Gillespie; William A Flavahan; Tyler E Miller; Andrew S Venteicher; Christine H Hebert; Christopher D Carey; Scott J Rodig; Sarah J Shareef; Fadi J Najm; Peter van Galen; Hiroaki Wakimoto; Daniel P Cahill; Jeremy N Rich; Jon C Aster; Mario L Suvà; Anoop P Patel; Bradley E Bernstein
Journal:  Cell Stem Cell       Date:  2016-12-15       Impact factor: 24.633

4.  Role of HSP27 in the multidrug sensitivity and resistance of colon cancer cells.

Authors:  Zhengyong Liu; Yi Liu; Yupeng Long; Baohua Liu; Xiangfeng Wang
Journal:  Oncol Lett       Date:  2020-01-07       Impact factor: 2.967

Review 5.  A glial blueprint for gliomagenesis.

Authors:  Dylan Laug; Stacey M Glasgow; Benjamin Deneen
Journal:  Nat Rev Neurosci       Date:  2018-07       Impact factor: 34.870

6.  Prognostic relevance of genetic alterations in diffuse lower-grade gliomas.

Authors:  Kosuke Aoki; Hideo Nakamura; Hiromichi Suzuki; Keitaro Matsuo; Keisuke Kataoka; Teppei Shimamura; Kazuya Motomura; Fumiharu Ohka; Satoshi Shiina; Takashi Yamamoto; Yasunobu Nagata; Tetsuichi Yoshizato; Masahiro Mizoguchi; Tatsuya Abe; Yasutomo Momii; Yoshihiro Muragaki; Reiko Watanabe; Ichiro Ito; Masashi Sanada; Hironori Yajima; Naoya Morita; Ichiro Takeuchi; Satoru Miyano; Toshihiko Wakabayashi; Seishi Ogawa; Atsushi Natsume
Journal:  Neuro Oncol       Date:  2018-01-10       Impact factor: 12.300

Review 7.  Targeting Notch3 in Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Perspectives.

Authors:  Catia Giovannini; Luigi Bolondi; Laura Gramantieri
Journal:  Int J Mol Sci       Date:  2016-12-28       Impact factor: 5.923

8.  Lunatic Fringe and p53 Cooperatively Suppress Mesenchymal Stem-Like Breast Cancer.

Authors:  Wen-Cheng Chung; Shubing Zhang; Lavanya Challagundla; Yunyun Zhou; Keli Xu
Journal:  Neoplasia       Date:  2017-09-19       Impact factor: 5.715

9.  Epigenetic regulation of NOTCH1 and NOTCH3 by KMT2A inhibits glioma proliferation.

Authors:  Yin-Cheng Huang; Sheng-Jia Lin; Hung-Yu Shih; Chung-Han Chou; Hsiao-Han Chu; Ching-Chi Chiu; Chiou-Hwa Yuh; Tu-Hsueh Yeh; Yi-Chuan Cheng
Journal:  Oncotarget       Date:  2017-06-27

10.  Antineoplastic effects of histone deacetylase inhibitors in neuroendocrine cancer cells are mediated through transcriptional regulation of Notch1 by activator protein 1.

Authors:  Samuel Jang; Haining Jin; Madhuchhanda Roy; Alice L Ma; Shaoqin Gong; Renata Jaskula-Sztul; Herbert Chen
Journal:  Cancer Med       Date:  2017-08-04       Impact factor: 4.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.